Daxor Net Profit Margin 2010-2011 | DXR

Daxor net profit margin from 2010 to 2011. Net profit margin can be defined as net Income as a portion of total sales revenue.
Daxor Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2011-12-31 $0.00B $-0.01B 0.00%
2011-09-30 $0.00B $0.00B 0.00%
2011-06-30 $0.00B $0.00B 0.00%
2011-03-31 $0.00B $0.00B 0.00%
2010-12-31 $0.00B $0.01B 0.00%
2010-09-30 $0.00B $0.00B 0.00%
2010-06-30 $0.00B $0.00B 0.00%
2010-03-31 $0.00B $0.01B 0.00%
2009-12-31 $0.00B $0.01B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.042B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.118B 19.83
Encompass Health (EHC) United States $12.188B 25.84
DaVita (DVA) United States $10.277B 14.45
Chemed (CHE) United States $8.063B 25.34
Elanco Animal Health (ELAN) United States $6.859B 14.69
Option Care Health (OPCH) United States $5.174B 23.07
RadNet (RDNT) United States $4.157B 263.86
Amedisys (AMED) United States $3.189B 21.45
Addus HomeCare (ADUS) United States $2.075B 22.79
LifeStance Health (LFST) United States $2.045B 0.00
Astrana Health (ASTH) United States $1.444B 35.76
U.S Physical Therapy (USPH) United States $1.170B 30.20
Aveanna Healthcare Holdings (AVAH) United States $0.958B 54.56
Pennant (PNTG) United States $0.954B 35.03
Atai Life Sciences (ATAI) Germany $0.423B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.044B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00